维普中文期刊产品整合服务
21篇 您的检索式:作者名="Fossmark"
    题名 作者 年代 出处 被引量
1Gastric cancer:Animal studies on the risk of hypoacidity and hypergastrinemia显示文摘Gastric hypoacidity and hypergastrinaemia are seen in several conditions associated with an increased risk of gastric malignancy.Hypoacidity and hypergastrinaemia are closely related and their long-term effects are difficult to study separately in patients.Studies using animal models can provide valuable information about risk factors and mechanisms in gastric cancer development as the models allow a high degree of intervention when introducing or eliminating factors possibly affecting carcinogenesis.In this report,we briefly review findings from relevant animal studies on this topic.Animal models of gastric hypoacidity and hypergastrinaemia provide evidence hypergastrinaemia is a common causative factor in many otherwise diverse settings.In all species where sufficient hypoacidity and hypergastrinaemia have been induced,a proportion of the animals develop malignant lesions in the gastric oxyntic mucosa.Reidar Fossmark Gunnar Qvigstad Helge L Waldum 2008World Journal of Gastroenterology2008,14,11:5
2The regulation of gastric acid secretion – clinical perspectives显示文摘H. L. Waldum ?. Hauso R. Fossmark 2014Acta Physiol2014,,2:1
3Antiulcer drugs and gastric cancer显示文摘Waldum HL Gustafsson B Fossmark R Qvigstad G 2005Dig Dis Sci2005,50,:1
4Ultrastructure and chromogranin A immunogold labelling of ECL cell carcinoids显示文摘Fossmark R Martinsen TC Qvigstad G 2005APMIS2005,113,78:1
5A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia 显示文摘Jianu CS Fossmark R Syversen U 2010Tumour BioI2010,31,5:1
6Ultrastructure and chro-mogranin A immunogold labelling of ECL cell earcinoids 显示文摘Fossmark R Martinsen TC Qvigstad G 2005APM/S2005,113,78:1
7Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A显示文摘R. Fossmark ?. S?rdal C. S. Jianu G. Qvigstad I. S. Nordrum M. Boyce H. L. Waldum 2012Aliment Pharmacol Ther (pt)2012,,11:1
8Gastric carcinoids after long-term use of a proton pump inhibitor显示文摘Jianu CS Fossmark R Viset T 2012Aliment Pharmacol Ther2012,36,7:1
9Gastric carcinoid after longterm use of a proton pump inhibitor显示文摘Jianu CS Fossmark R Viset T 2012Aliment Pharmacol Ther2012,36,7:1
10The regulation of gastric acid secretion-clinical perspectives显示文摘Waldum H L Hauso Fossmark R 2014Acta Physiol(Oxf)2014,210,2:1
11Uhrastructure and chromogranin A immunogold labelling of ECL cell carcinoids 显示文摘Fossmark R Martinsen TC Qvigstad G 2005APMIS2005,113,78:1
12Rebound acid hypersecretion after long - term inhibition of gastric acid secretion显示文摘Fossmark R Johnsen G Johanessen E 2005Aliment Pharmacol Ther2005,21,2:1
13Signet ring cells in gastric-carcinomas are derived fromneuroendocrine cells显示文摘BakkelundK Fossmark R NordrumI 0,,:1
14Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition显示文摘FOSSMARK R JIANU CS MARTINSEN TC 2008Scand J Gastroenterol2008,43,1:1
15Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice 显示文摘Fossmark R Stunes AK Petzold C 2012J Cell Biochem2012,113,1:1
16Gastric carcinomas localized to the cardia显示文摘Bakkelund KE Nordrum IS Fossmark R 2012Gastroenterol Res Pract2012,2012,45:1
17Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids显示文摘Constantin S. Jianu Reidar Fossmark Unni Syversen ? yvind Hauso Vidar Fykse Helge L. Waldum 2011Scandinavian Journal of Gastroenterology2011,,4:1
18The regulation of gastric acid secretion-clinical perspectives显示文摘Waldum HL Hauso O Fossmark R 2014Acta physiologica2014,18,210:1
19Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A显示文摘R. Fossmark ?. S?rdal C. S. Jianu G. Qvigstad I. S. Nordrum M. Boyce H. L. Waldum 2012Aliment Pharmacol Ther . 2012 (11pt)2012,,11:1
20Neuroendocrine cells in diffuse gastric carcinomas: an ultrastructural study with immunogold labeling of Chromogranin A显示文摘MARTINSEN C T SKOGAKER E T N FOSSMARK R 2010Applied Immunohistochemistry & Molecular Morphology2010,18,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费